Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
February 10, 2010
Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors
Gabriella Traquandi, Marina Ciomei, Dario Ballinari, et al.
Journal of Medicinal Chemistry
|
February 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase
Daniela Angst, François Gessier, Philipp Janser, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field
Anna Vulpetti, Philipp Holzer, Niko Schmiedeberg, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Bioconjugate Chemistry
|
January 24, 2024
Design, Synthesis, and In Vitro and In Vivo Evaluation of Cereblon Binding Bruton's Tyrosine Kinase (BTK) Degrader CD79b Targeted Antibody-Drug Conjugates
Alan Zhang, Katherine Seiss, Laurent Laborde, et al.
Chemmedchem
|
April 24, 2007
6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitors
Maria Gabriella Brasca, Clara Albanese, Raffaella Amici, et al.
Journal of Medicinal Chemistry
|
July 17, 2009
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor
Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, et al.
Journal of Medicinal Chemistry
|
April 15, 2005
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization
Paolo Pevarello, Maria Gabriella Brasca, Paolo Orsini, et al.
Bioorganic & Medicinal Chemistry
|
February 16, 2010
Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing
Maria Gabriella Brasca, Clara Albanese, Rachele Alzani, et al.
Journal of Medicinal Chemistry
|
April 15, 2005
Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition
Daniele Fancelli, Daniela Berta, Simona Bindi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
February 10, 2010
Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors
Gabriella Traquandi, Marina Ciomei, Dario Ballinari, et al.
Journal of Medicinal Chemistry
|
February 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase
Daniela Angst, François Gessier, Philipp Janser, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field
Anna Vulpetti, Philipp Holzer, Niko Schmiedeberg, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Bioconjugate Chemistry
|
January 24, 2024
Design, Synthesis, and In Vitro and In Vivo Evaluation of Cereblon Binding Bruton's Tyrosine Kinase (BTK) Degrader CD79b Targeted Antibody-Drug Conjugates
Alan Zhang, Katherine Seiss, Laurent Laborde, et al.
Chemmedchem
|
April 24, 2007
6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitors
Maria Gabriella Brasca, Clara Albanese, Raffaella Amici, et al.
Journal of Medicinal Chemistry
|
July 17, 2009
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor
Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, et al.
Journal of Medicinal Chemistry
|
April 15, 2005
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization
Paolo Pevarello, Maria Gabriella Brasca, Paolo Orsini, et al.
Bioorganic & Medicinal Chemistry
|
February 16, 2010
Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing
Maria Gabriella Brasca, Clara Albanese, Rachele Alzani, et al.
Journal of Medicinal Chemistry
|
April 15, 2005
Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition
Daniele Fancelli, Daniela Berta, Simona Bindi, et al.
Page
of 6